CANNABIS GLOBAL, INC. (CBGL) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
520 S. GRAND AVENUE LOS ANGELES, CA 90071 |
| State of Incorp. | NV |
| Fiscal Year End | August 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 5/31/2022 Q3 | 2/28/2022 Q2 | 11/30/2021 Q1 | 8/31/2021 Q4 | 5/31/2021 Q3 | 2/28/2021 Q2 | 11/30/2020 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 604 | 89 | 31 | 268 | 134 | 60 | |||
| Cash and cash equivalent | 604 | 89 | 31 | 268 | 134 | 60 | |||
| Receivables | 452 | 274 | 154 | 400 | 259 | 1 | |||
| Inventory, net of allowances, customer advances and progress billings | 196 | 324 | 189 | 182 | 180 | 76 | |||
| Inventory | 196 | 324 | 189 | 182 | 180 | 76 | |||
| Prepaid expense | |||||||||
| Other current assets | 10 | 6 | 8 | ||||||
| Other undisclosed current assets | 21 | 60 | 60 | 60 | 80 | ||||
| Total current assets: | 1,283 | 752 | 442 | 910 | 654 | 137 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 600 | 617 | 635 | 607 | 607 | ||||
| Property, plant and equipment | 1,016 | 152 | 219 | 1,433 | 1,362 | 25 | |||
| Long-term investments and receivables | 407 | 607 | 650 | 650 | 650 | 2,513 | |||
| Long-term investments | 407 | 607 | 650 | 650 | 650 | 2,513 | |||
| Intangible assets, net (including goodwill) | 11,795 | 9,343 | 9,343 | 8,599 | 8,599 | ||||
| Goodwill | 7,925 | 8,843 | 8,843 | 8,099 | 8,099 | ||||
| Intangible assets, net (excluding goodwill) | 3,870 | 500 | 500 | 500 | 500 | ||||
| Other undisclosed noncurrent assets | 48 | 48 | 51 | 48 | 48 | 507 | |||
| Total noncurrent assets: | 13,866 | 10,768 | 10,897 | 11,338 | 11,266 | 3,045 | |||
| TOTAL ASSETS: | 15,148 | 11,520 | 11,339 | 12,247 | 11,920 | 3,181 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 892 | 949 | 943 | 834 | 603 | 342 | |||
| Interest and dividends payable | 147 | 212 | 212 | 210 | 139 | 96 | |||
| Accounts payable | 744 | 736 | 731 | 624 | 463 | 246 | |||
| Accrued liabilities | |||||||||
| Debt | 2,020 | 1,558 | 1,384 | 2,099 | 1,704 | 2,124 | |||
| Derivative instruments and hedges, liabilities | 1,942 | 2,154 | 4,748 | 3,586 | 2,055 | 1,140 | |||
| Due to related parties | 111 | 111 | 111 | 625 | 618 | 501 | |||
| Other undisclosed current liabilities | 997 | 1,296 | 1,562 | 197 | 2,010 | ||||
| Total current liabilities: | 5,962 | 6,068 | 8,747 | 7,340 | 6,989 | 4,107 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,255 | 1,307 | 1,236 | 1,331 | 672 | ||||
| Long-term debt, excluding current maturities | 731 | 763 | 673 | 786 | 127 | ||||
| Operating lease, liability | 524 | 544 | 563 | 545 | 545 | ||||
| Other undisclosed noncurrent liabilities | (524) | (544) | (563) | (545) | (545) | ||||
| Total noncurrent liabilities: | 1,255 | 1,307 | 673 | 1,331 | 672 | ||||
| Total liabilities: | 7,217 | 7,375 | 9,983 | 8,672 | 7,661 | 4,107 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 3,492 | 588 | (2,212) | (366) | 410 | (926) | |||
| Preferred stock | 1 | 1 | 1 | 1 | 1 | 1 | |||
| Common stock | 509 | 212 | 85 | 79 | 66 | 40 | |||
| Additional paid in capital | 16,995 | 13,885 | 11,592 | 10,883 | 8,863 | 5,442 | |||
| Accumulated deficit | (14,016) | (13,512) | (13,892) | (11,329) | (8,521) | (6,410) | |||
| Other undisclosed equity, attributable to parent | 2 | 2 | 2 | 1 | 1 | 2 | |||
| Equity, attributable to noncontrolling interest | 4,440 | 3,557 | 3,568 | 3,942 | 3,849 | ||||
| Total equity: | 7,931 | 4,145 | 1,356 | 3,576 | 4,259 | (926) | |||
| Other undisclosed liabilities and equity | (607) | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 15,148 | 11,520 | 11,339 | 11,640 | 11,920 | 3,181 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 5/31/2022 Q3 | 2/28/2022 Q2 | 11/30/2021 Q1 | 8/31/2021 Q4 | 5/31/2021 Q3 | 2/28/2021 Q2 | 11/30/2020 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 627 | 570 | 630 | 940 | 26 | 5 | ||
| Gain (loss) on disposition of assets for financial service operations | 1,716 | 1,773 | (697) | 1,410 | 593 | 716 | ||
| Other income | 2 | 148 | ||||||
| Cost of revenue | (768) | (456) | (679) | (730) | (7) | (1) | ||
| Gross profit: | (141) | 114 | (49) | 211 | 19 | 3 | ||
| Operating expenses | (938) | (335) | (542) | (707) | (432) | (447) | ||
| Operating loss: | (1,079) | (221) | (591) | (496) | (412) | (444) | ||
| Nonoperating income (expense) | 382 | 589 | (2,345) | (2,220) | (1,698) | 91 | ||
| Interest and debt expense | (2,488) | (1,255) | (1,101) | (3,630) | (1,934) | (773) | ||
| Loss from continuing operations before equity method investments, income taxes: | (3,185) | (887) | (4,037) | (6,346) | (4,044) | (1,126) | ||
| Loss from equity method investments | (359) | |||||||
| Loss from continuing operations: | (3,185) | (887) | (4,037) | (6,346) | (4,404) | (1,126) | ||
| Loss before gain (loss) on sale of properties: | (3,185) | (887) | (4,037) | (6,346) | (4,404) | (1,126) | ||
| Other undisclosed net income | 2,488 | 1,255 | 1,101 | 3,630 | 2,293 | 773 | ||
| Net income (loss): | (697) | 368 | (2,936) | (2,716) | (2,111) | (353) | ||
| Net income (loss) attributable to noncontrolling interest | 194 | 12 | 373 | (92) | ||||
| Other undisclosed net loss attributable to parent | (194) | (12) | ||||||
| Net income (loss) attributable to parent: | (697) | 368 | (2,563) | (2,808) | (2,111) | (353) | ||
| Other undisclosed net income available to common stockholders, basic | 92 | |||||||
| Net income (loss) available to common stockholders, basic: | (697) | 368 | (2,563) | (2,716) | (2,111) | (353) | ||
| Other undisclosed net loss available to common stockholders, diluted | (10,452) | |||||||
| Net income (loss) available to common stockholders, diluted: | (697) | 368 | (13,015) | (2,716) | (2,111) | (353) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 5/31/2022 Q3 | 2/28/2022 Q2 | 11/30/2021 Q1 | 8/31/2021 Q4 | 5/31/2021 Q3 | 2/28/2021 Q2 | 11/30/2020 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (697) | 368 | (2,936) | (2,716) | (2,111) | (353) | ||
| Other comprehensive income | 935 | |||||||
| Comprehensive income (loss): | 238 | 368 | (2,936) | (2,716) | (2,111) | (353) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 194 | 12 | 373 | (92) | ||||
| Comprehensive income (loss), net of tax, attributable to parent: | 431 | 380 | (2,563) | (2,808) | (2,111) | (353) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.